Fly News Breaks for February 4, 2020
Feb 4, 2020 | 08:27 EDT
Argus analyst Kevin Heal raised his price target on Ameriprise to $190 and kept his Buy rating, saying the company's revenue growth in recent quarters has been "steady" amid strong growth in assets under management. The analyst adds that while the company is facing pressure from a flattening yield curve, he expects its future growth to be driven by "equity market volatility, an increase in fee-based accounts, and improving revenues from asset manager Columbia Threadneedle."
News For AMP From the Last 2 Days
There are no results for your query AMP